# Intervene Immune, Inc. — Form D

Intervene Immune, Inc. of MANHATTAN BEACH, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-27. $471K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-12-27
- Form: D
- Accession: 0001797564-19-000001
- Industry: Biotechnology
- Exemptions: 04, 06b, 4a5
- Amount sold: $471K
- Investors: 6
- Date of first sale: 2013-11-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-356563

## Issuer

- Name: Intervene Immune, Inc.
- CIK: 0001797564
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 1601 N. SEPULVEDA BOULEVARD, MANHATTAN BEACH, CA, 90266
- Phone: (513) 341-5412

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Robert Brooke | Director | Manhattan Beach, CA |
| Gregory Fahy | Director | Manhattan Beach, CA |
| Philip Kernan Jr. | Director | Manhattan Beach, CA |
| Robert Brooke | Executive Officer | Manhattan Beach, CA |
| Gregory Fahy | Executive Officer | Manhattan Beach, CA |
| Paul Hynek | Executive Officer | Manhattan Beach, CA |
| Philip Kernan Jr. | Executive Officer | Manhattan Beach, CA |

## More

- [CIK 1797564 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1797564&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001797564-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
